Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Kaufeld

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Innere Medizin (Heidelberg, Germany)|November 18, 2024
[What is proven in the treatment of complement-mediated kidney diseases?]Jessica Kaufeld, Svjetlana Lovric
Blood Pressure|February 9, 2026
Long-Term Efficacy and Safety of First- and Second-Generation Baroreflex Activation Devices in Refractory Hypertension: A Single Center Retrospective AnalysisJessica Kaufeld, Ruha Younes, Thomas Aper, et al.
Transplantation Direct|May 21, 2024
Left Ventricular Hypertrophy After Renal Transplantation: Systematic Review and Meta-analysisZhejia Tian, Kai Bergmann, Jessica Kaufeld, et al.
Der Internist|April 20, 2018
[Cystinosis : Diagnosis, cystine-depleting therapy, and transition]Jessica Kaufeld, Lutz T Weber, Christine Kurschat, et al.
BMC Health Services Research|September 10, 2021
Health economic benefits through the use of diagnostic support systems and expert knowledgeTina Willmen, Lukas Völkel, Simon Ronicke, et al.
Orphanet Journal of Rare Diseases|February 20, 2025
Impact of enzyme replacement therapy and migalastat on disease progression in females with fabry diseaseMalte Lenders, Albina Nowak, Markus Cybulla, et al.
Orphanet Journal of Rare Diseases|December 28, 2024
Impact of enzyme replacement therapy on clinical manifestations in females with Fabry diseaseMalte Lenders, Albina Nowak, Markus Cybulla, et al.
Biomed Research International|October 10, 2013
"Zebrafishing" for novel genes relevant to the glomerular filtration barrierNils Hanke, Lynne Staggs, Patricia Schroder, et al.
BMC Nephrology|June 19, 2024
Clinical efficacy and safety of switching from eculizumab to ravulizumab in adult patients with aHUS- real-world dataKristina Schönfelder, Lucas Kühne, Lena Schulte-Kemna, et al.
Journal of Thrombosis and Haemostasis : JTH|August 7, 2020
Treatment of acquired thrombotic thrombocytopenic purpura without plasma exchange in selected patients under caplacizumabLinus A Völker, Paul T Brinkkoetter, Paul N Knöbl, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Innere Medizin (Heidelberg, Germany)|November 18, 2024
[What is proven in the treatment of complement-mediated kidney diseases?]Jessica Kaufeld, Svjetlana Lovric
Blood Pressure|February 9, 2026
Long-Term Efficacy and Safety of First- and Second-Generation Baroreflex Activation Devices in Refractory Hypertension: A Single Center Retrospective AnalysisJessica Kaufeld, Ruha Younes, Thomas Aper, et al.
Transplantation Direct|May 21, 2024
Left Ventricular Hypertrophy After Renal Transplantation: Systematic Review and Meta-analysisZhejia Tian, Kai Bergmann, Jessica Kaufeld, et al.
Der Internist|April 20, 2018
[Cystinosis : Diagnosis, cystine-depleting therapy, and transition]Jessica Kaufeld, Lutz T Weber, Christine Kurschat, et al.
BMC Health Services Research|September 10, 2021
Health economic benefits through the use of diagnostic support systems and expert knowledgeTina Willmen, Lukas Völkel, Simon Ronicke, et al.
Orphanet Journal of Rare Diseases|February 20, 2025
Impact of enzyme replacement therapy and migalastat on disease progression in females with fabry diseaseMalte Lenders, Albina Nowak, Markus Cybulla, et al.
Orphanet Journal of Rare Diseases|December 28, 2024
Impact of enzyme replacement therapy on clinical manifestations in females with Fabry diseaseMalte Lenders, Albina Nowak, Markus Cybulla, et al.
Biomed Research International|October 10, 2013
"Zebrafishing" for novel genes relevant to the glomerular filtration barrierNils Hanke, Lynne Staggs, Patricia Schroder, et al.
BMC Nephrology|June 19, 2024
Clinical efficacy and safety of switching from eculizumab to ravulizumab in adult patients with aHUS- real-world dataKristina Schönfelder, Lucas Kühne, Lena Schulte-Kemna, et al.
Journal of Thrombosis and Haemostasis : JTH|August 7, 2020
Treatment of acquired thrombotic thrombocytopenic purpura without plasma exchange in selected patients under caplacizumabLinus A Völker, Paul T Brinkkoetter, Paul N Knöbl, et al.
Pageof 4